PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

Background: Tumor microenvironment may have a key role in providing immunological markers that can help predict clinical response to treatment with checkpoint inhibitors. We investigated whether the baseline expression of PD-L1 in advanced melanoma patients treated with ipilimumab may correlate with...

Full description

Bibliographic Details
Main Authors: Gabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, Carlo Bifulco, Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, Ester Simeone, Antonio M. Grimaldi, Corrado Caracò, Gerardo Botti, Bernard A. Fox, Paolo A. Ascierto
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:OncoImmunology
Subjects:
immunotherapy
ipilimumab
melanoma
pd-l1
tumor microenvironment
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1405206

Internet

http://dx.doi.org/10.1080/2162402X.2017.1405206

Similar Items